POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ('IGC Pharma' or the 'Company') announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

Avik Pal, CliniOps' CEO, expressed enthusiasm for the collaboration, stating, 'This partnership is an exciting opportunity for CliniOps and Indegene to complement each other's strengths, to ultimately ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...

Research projects that generative AI could boost the pharma and medical-product industries' annual revenues by up to $110 ...

The "Strategic Intelligence: Big Data in Pharma" report has been added to ResearchAndMarkets.com's offering. A dedicated report examining the pivotal healthcare, technological, macroeconomic, and ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.B9uuF-Zi.js ...

The AI in cancer care market is set to grow from $2.2 billion in 2024 to $6.3 billion by 2029, driven by advancements in drug ...

Full mergers and acquisitions in the pharmaceutical and biotechnology in 2024 fluctuated throughout the year with hardly any in some months and a significant number in other. But one thing was clear – ...

We’ve seen several high-profile transactions in life sciences, resulting in big exits for investors in the private and public ...